Geode Capital Management LLC grew its position in UiPath Inc. (NYSE:PATH - Free Report) by 7.2% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 7,312,068 shares of the company's stock after purchasing an additional 493,502 shares during the period. Geode Capital Management LLC owned about 1.33% of UiPath worth $93,619,000 as of its most recent filing with the SEC.
Other large investors have also made changes to their positions in the company. Pacer Advisors Inc. acquired a new stake in UiPath during the 2nd quarter valued at $69,180,000. Jacobs Levy Equity Management Inc. increased its stake in shares of UiPath by 554.8% in the third quarter. Jacobs Levy Equity Management Inc. now owns 4,026,502 shares of the company's stock valued at $51,539,000 after buying an additional 3,411,562 shares in the last quarter. Senvest Management LLC raised its holdings in shares of UiPath by 16.7% in the third quarter. Senvest Management LLC now owns 10,894,483 shares of the company's stock valued at $139,449,000 after buying an additional 1,559,500 shares during the last quarter. Worldquant Millennium Advisors LLC acquired a new position in UiPath during the 3rd quarter worth about $19,071,000. Finally, Renaissance Technologies LLC bought a new stake in UiPath during the 2nd quarter worth about $13,280,000. Institutional investors own 62.50% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have weighed in on the stock. Barclays boosted their target price on shares of UiPath from $15.00 to $16.00 and gave the stock an "equal weight" rating in a research note on Friday, December 6th. BMO Capital Markets boosted their price objective on shares of UiPath from $15.00 to $16.00 and gave the stock a "market perform" rating in a research report on Friday, December 6th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $16.00 price objective on shares of UiPath in a research report on Friday, December 6th. JPMorgan Chase & Co. boosted their target price on UiPath from $17.00 to $18.00 and gave the stock an "overweight" rating in a research report on Friday, December 6th. Finally, UBS Group began coverage on UiPath in a research note on Thursday, December 12th. They set a "sell" rating and a $14.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, sixteen have assigned a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, UiPath has a consensus rating of "Hold" and a consensus target price of $17.50.
View Our Latest Stock Analysis on UiPath
UiPath Price Performance
PATH traded up $0.51 during mid-day trading on Friday, hitting $13.25. The stock had a trading volume of 14,135,841 shares, compared to its average volume of 9,693,652. UiPath Inc. has a 1-year low of $10.37 and a 1-year high of $27.87. The firm has a market capitalization of $7.28 billion, a price-to-earnings ratio of -82.81 and a beta of 0.94. The stock's fifty day simple moving average is $13.42 and its 200-day simple moving average is $12.62.
UiPath Profile
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
See Also
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.